A Case of McLeod’s Syndrome Presenting with Severe Decompensated Heart Failure

Hemanth K. Boppana; Samarthkumar Thakkar; Harsh P. Patel; Rody G. Bou Chaaya; Scott Feitell

doi:10.14797/mdcvj.1164

A Case of McLeod’s Syndrome Presenting with Severe Decompensated Heart Failure

Methodist DeBakey Cardiovascular Journal

Volume 19 (2023): Issue 1

By: Hemanth K. Boppana , Samarthkumar Thakkar , Harsh P. Patel , Rody G. Bou Chaaya and Scott Feitell

Open Access

|Sep 2023

Abstract

McLeod’s syndrome (MLS) is an X-linked disorder caused by mutations in the XK gene with neurological manifestations as well as cardiomyopathy. This is a case of acute exacerbation of heart failure in a 44-year-old White male with a confirmed diagnosis of MLS, which was managed with guideline-directed medical therapy and placement of an implantable cardioverter defibrillator with recovery in ejection fraction.

References

Jung HH, Danek A, Walker RH, Frey BM, Peikert K. McLeod Neuroacanthocytosis Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle, WA: University of Washington; 1993-2023.
Search in Google Scholar Back to article
Witt TN, Danek A, Reiter M, Heim MU, Dirschinger J, Olsen EG. McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations. J Neurol. 1992 Jul;239(6):302-6. doi: 10.1007/BF00867584
Open DOI Search in Google Scholar Back to article
Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol. 2001 Dec;50(6):755-64. doi: 10.1002/ana.10035
Open DOI Search in Google Scholar Back to article
Quick S, Heidrich FM, Winkler M-V, et al. Cardiac manifestation is evident in chorea-acanthocytosis but different from McLeod syndrome. Parkinsonism Relat Disord. 2021 Jul;88:90-95. doi: 10.1016/j.parkreldis.2021.05.015
Open DOI Search in Google Scholar Back to article
Writing Committee; Maddox TM, Januzzi JL Jr., Allen LA, et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Feb 16;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1164 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 75 - 78

Submitted on: Jun 26, 2023

Accepted on: Jul 18, 2023

Published on: Sep 14, 2023

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

McLeod’s syndrome,

guideline-directed medical therapy,

implantable cardioverter defibrillator,

late galodinium enhancement

© 2023 Hemanth K. Boppana, Samarthkumar Thakkar, Harsh P. Patel, Rody G. Bou Chaaya, Scott Feitell, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 19 (2023): Issue 1